Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
7961 items from SEC EDGAR · filings · clear filters
- 8-K - ExchangeRight Income Fund (0001771514) (Filer)
ExchangeRight Income Fund filed a Form 8-K on October 14, 2026, reporting director and officer departures, elections, appointments, and related compensatory arrangements, together with financial statements and accompanying exhibits.
- 8-K - StageWise Strategies Corp. (0001999261) (Filer)
StageWise Strategies Corp. filed an 8-K reporting the completion of an acquisition, unregistered equity sales, changes in control, director and officer departures, elections, appointments and compensation arrangements, amendments to its charter and fiscal year, and accompanying financial statements.
- 8-K - USBC, Inc. (0001074828) (Filer)
USBC, Inc. filed an 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation or off-balance-sheet arrangement, other events, and accompanying financial statements and exhibits.
- 8-K - Gemini Space Station, Inc. (0002055592) (Filer)
Gemini Space Station, Inc. filed a Form 8-K on October 14, 2026 (Accession No. 0001104659-26-115771), reporting Item 8.01 Other Events and providing Item 9.01 Financial Statements and related exhibits.
- 8-K - SkinHealth Systems Inc. (0001818093) (Filer)
SkinHealth Systems Inc. filed a Form 8-K on October 14, 2026 reporting material modifications to security-holder rights, amendments to its articles of incorporation and bylaws, including a change in fiscal year, along with Regulation FD disclosures and financial statements.
- 8-K - PC CONNECTION INC (0001050377) (Filer)
PC Connection Inc. filed a Form 8-K on October 14, 2026, disclosing departures, elections, appointments, and compensatory arrangements for certain officers, and providing its financial statements and related exhibits.
- 8-K - KULICKE & SOFFA INDUSTRIES INC (0000056978) (Filer)
Kulicke & Soffa Industries Inc. filed a Form 8-K on October 14, 2026, disclosing director and officer departures, elections, appointments, related compensatory arrangements, and providing its financial statements and accompanying exhibits.
- 8-K - BASSETT FURNITURE INDUSTRIES INC (0000010329) (Filer)
Basset Furniture Industries Inc. filed a Form 8-K on October 14, 2026 (Accession No. 0001437749-26-032602), reporting Item 8.01 other events and Item 9.01 financial statements and exhibits.
- 8-K - TOP Financial Group Ltd (0001848275) (Filer)
TOP Financial Group Ltd filed a Form 8-K on October 14, 2026, containing a Regulation FD disclosure and the company’s financial statements and related exhibits.
- 8-K - Cartesian Growth Corp II (0001889112) (Filer)
Cartesian Growth Corp II filed a Form 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation or off-balance sheet arrangement, and the inclusion of financial statements and related exhibits.
- 8-K - PROGRESSIVE CORP/OH/ (0000080661) (Filer)
Progressive Corp filed a Form 8-K on October 14, 2026, including Item 2.02 covering results of operations and financial condition and Item 9.01 containing financial statements and exhibits.
- 8-K - Liberty Global Ltd. (0001570585) (Filer)
Liberty Global Ltd. filed a Form 8-K on October 14, 2026, including Item 2.02 covering its results of operations and financial condition and Item 9.01 containing its financial statements and related exhibits.
- 8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer)
Ultragenyx Pharmaceutical Inc. filed a Form 8-K on October 14, 2026 (Accession No. 0001193125-26-421079) reporting entry into a material definitive agreement.
- 8-K - Alector, Inc. (0001653087) (Filer)
Alector, Inc. filed a Form 8-K reporting the departure of certain directors or officers, the election or appointment of new directors and officers, and disclosed compensatory arrangements for the appointed officers.
- 8-K - Nordicus Partners Corp (0001011060) (Filer)
Nordicus Partners Corp filed a Form 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation or off-balance-sheet arrangement, and the inclusion of financial statements and related exhibits.
- 8-K - SKYX Platforms Corp. (0001598981) (Filer)
SKYX Platforms Corp filed a Form 8-K reporting a material definitive agreement, completion of an acquisition, creation of a direct financial obligation, unregistered sales of equity securities, and related financial statements and exhibits.
- 8-K - Aptevo Therapeutics Inc. (0001671584) (Filer)
Aptevo Therapeutics filed a Form 8-K on October 14, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Integer Holdings Corp (0001114483) (Filer)
Integer Holdings Corp filed a Form 8-K under Item 8.01 (Other Events) with the SEC on October 14, 2026 (Accession No. 0000950103-26-015548).
- 8-K - Evolution Metals & Technologies Corp. (0001866226) (Filer)
Evolution Metals & Technologies Corp. filed a Form 8-K on October 14, 2026, containing a Regulation FD disclosure and the company’s financial statements and related exhibits.
- 8-K - PULSE BIOSCIENCES, INC. (0001625101) (Filer)
Pulse Biosciences, Inc. filed a Form 8-K on October 14, 2026, containing Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Eagle Point Credit Co (0001604174) (Filer)
Eagle Point Credit Co. filed a Form 8-K reporting an Item 8.01 “Other Events” on October 14, 2026.
- 8-K - Data443 Risk Mitigation, Inc. (0001068689) (Filer)
Data443 Risk Mitigation, Inc. filed a Form 8-K with the SEC on October 14, 2026, including a Regulation FD disclosure (Item 7.01) and accompanying financial statements and exhibits (Item 9.01).
- 8-K - Vir Biotechnology, Inc. (0001706431) (Filer)
Vir Biotechnology filed a Form 8-K reporting unregistered sales of equity securities, other events, and accompanying financial statements and exhibits.
- 8-K - Datacentrex, Inc. (0001853825) (Filer)
Datacentrex, Inc. filed a Form 8-K on October 14, 2026, reporting other events under Item 8.01 and providing financial statements and related exhibits under Item 9.01.
- 8-K - Eagle Point Income Co (0001754836) (Filer)
Eagle Point Income Co filed a Form 8-K with the SEC on October 14, 2026, reporting an Item 8.01 “Other Events” disclosure.
- 8-K - Coya Therapeutics, Inc. (0001835022) (Filer)
Coya Therapeutics, Inc. filed a Form 8-K with the SEC on October 14, 2026, under Item 8.01 (Other Events), accession number 0001193125-26-421066, comprising a 148 KB document.
- 8-K - Valion Bio, Inc. (0001787740) (Filer)
Valion Bio, Inc. filed a Form 8-K on October 14, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - FLEX LTD. (0000866374) (Filer)
Flex Ltd. filed a Form 8-K reporting entry into a material definitive agreement, completion of an acquisition or asset disposition, creation of a direct financial obligation, other events, and accompanying financial statements and exhibits.
- 8-K - MAXCYTE, INC. (0001287098) (Filer)
MaxCyte, Inc. filed a Form 8-K on October 14, 2026, reporting its results of operations and financial condition under Item 2.02, and providing financial statements and related exhibits under Item 9.01.
- 8-K - Sabre Corp (0001597033) (Filer)
Sabre Corp filed a Form 8-K on October 14, 2026, reporting the termination of a material definitive agreement and providing information under Item 8.01 regarding other events.